Despina Bozoudi | Microbiology | Research Excellence Award

Published on by Medical Lab Scientist

Ms. Despina Bozoudi | Microbiology | Research Excellence Award

Public Health Inspector | Pafos Municipality | Cyprus

Ms. Despina Bozoudi is a researcher in food microbiology and dairy science with a strong focus on the microbiological, physicochemical, and molecular characterization of traditional fermented foods, particularly PDO cheeses and dairy products. Her research integrates microbial ecology, lactic acid bacteria diversity, yeast functionality, and volatile compound profiling to support authenticity, quality, and safety of traditional foods. She has contributed to studies on Feta, Graviera, Trachanas, and other fermented matrices, as well as to broader themes such as grape and wine microbiomes and probiotic potential of indigenous strains. Her scholarly output includes 11 peer-reviewed documents, encompassing original research articles, review papers, and book chapters published in international journals and edited volumes. Collectively, her work has received 340 citations and reflects a sustained impact in the fields of food microbiology, dairy technology, and fermentation science, with an established h-index of 9, highlighting both productivity and citation influence within her research domain.

Citation Metrics (Scopus)

400

300

200

100

0

 

340
Citations

11
Documents

9
h-index

Citations

Documents

h-index

Featured Publications

Bineeta Kashyap | Microbiology | Research Excellence Award

Published on by Medical Lab Scientist

Prof. Dr. Bineeta Kashyap | Microbiology | Research Excellence Award

Director Professor | University College Of Medical Sciences | India

Dr. Bineeta Kashyap is a research-focused medical microbiologist with sustained contributions to clinical microbiology, infectious diseases, and translational diagnostics. Her scholarly work spans tuberculosis, antimicrobial resistance, hospital-acquired infections, molecular diagnostics, mycology, immunological biomarkers, and infection control, with particular emphasis on clinically relevant and resource-adapted diagnostic strategies. She has authored 77 peer-reviewed research documents, reflecting methodological rigor and breadth across bacteriology, virology, mycology, and immunopathogenesis. Her research output has accrued 806 citations, underscoring consistent scientific impact and relevance to both laboratory and clinical practice, and she holds an h-index of 14, indicating a solid body of influential work. Her publications integrate molecular techniques, biomarker discovery, and epidemiological surveillance to address pressing challenges in infectious disease diagnosis and management. Collectively, her research demonstrates sustained academic productivity, interdisciplinary collaboration, and a strong commitment to evidence-based advancement of microbiological science.

Citation Metrics (Scopus)

1000

750

500

250

0

 

806
Citations

77
Documents

14
h-index

Citations

Documents

h-index

Featured Publications

Sourabh Kumar | Microbiology | Research Excellence Award

Published on by Medical Lab Scientist

Dr. Sourabh Kumar | Microbiology | Research Excellence Award

Assistant Professor | Maharishi Markandeshwar Medical College and Hospital | India

Dr. Sourabh Kumar is an academic pathologist with a focused research portfolio spanning infectious diseases, hematopathology, and cardiovascular biomarkers. His scholarly work emphasizes Mycoplasma pneumoniae–associated pediatric respiratory infections and the clinicopathological relevance of platelet parameters and von Willebrand factor in valvular heart disease, particularly aortic stenosis. He has authored peer-reviewed articles in national and international medical journals and has contributed extensively to standard microbiology textbooks through multiple invited chapters covering infective syndromes, autoimmunity, hypersensitivity reactions, biomedical waste management, and microscopy. His research output demonstrates a translational approach, integrating laboratory diagnostics with clinical disease severity and prognostication. The body of work reflects sustained academic engagement, with 33 citations, 2 citable research documents, and an h-index of 1, indicating emerging impact in pathology and clinical microbiology literature.

Citation Metrics (Scopus)

40
30
20
10
0

33
Citations

2
Documents

1
h-index

Citations

Documents

h-index

Featured Publications

Surinder Kumar | Microbiology | Outstanding Scientist Award

Published on by Medical Lab Scientist

Prof. Surinder Kumar | Microbiology | Outstanding Scientist Award

Professor | Maulana Azad Medical College | India

Dr. Surinder Kumar is a senior researcher in medical microbiology with a sustained focus on respiratory and neonatal infectious diseases, molecular diagnostics, and clinical epidemiology. His research portfolio encompasses 49 peer-reviewed scientific documents that collectively account for 1105 citations with an h-index of 15, reflecting consistent scholarly impact and knowledge translation. His work has substantially advanced understanding of Mycoplasma pneumoniae and Chlamydophila pneumoniae in community-acquired lower respiratory tract infections, pediatric asthma exacerbations, and neonatal sepsis, integrating serology, culture, and PCR-based approaches. He has led and collaborated on competitively funded projects supported by national research agencies, addressing pathogen detection, antimicrobial resistance, and biomarker-driven diagnostics. His publications span high-quality national and international journals and are complemented by authoritative academic textbooks that support microbiology education and research methodology. His contributions continue to influence clinical microbiology practices, translational research frameworks, and evidence-based infectious disease diagnostics.

Citation Metrics (Scopus)

1200
900
600
300
0

1105
Citations

49
Documents

15
h-index

Citations

Documents

h-index

Featured Publications

Debasish Biswal | Microbiology | Young Scientist Award

Published on by Medical Lab Scientist

Assist. Prof. Dr. Debasish Biswal | Microbiology | Young Scientist Award

Assistant Professor | All India Institute of Medical Sciences | India

Dr. Debasish Biswal is a medical microbiologist with a strong research portfolio focused on antimicrobial resistance, molecular diagnostics, infection prevention, and intensive-care–associated infections. His scholarly output comprises 26 peer-reviewed research documents, collectively accruing 45 citations with an h-index of 4, reflecting sustained impact across clinical and translational microbiology. His work spans carbapenemase detection, synergy testing of novel β-lactam/β-lactamase inhibitor combinations, rapid molecular diagnostics for bacterial meningitis and tuberculosis, and genomic epidemiology of multidrug-resistant pathogens. He has contributed to high-impact journals in medical microbiology, critical care, infectious diseases, and parasitology, often integrating laboratory diagnostics with clinical outcomes and infection control strategies. Ongoing research includes evaluation of next-generation antimicrobial combinations against extensively drug-resistant organisms and assessment of advanced molecular platforms for extrapulmonary tuberculosis. His research emphasizes evidence-based antimicrobial stewardship, surveillance of healthcare-associated infections, and translational diagnostics to inform policy and clinical practice.

Citation Metrics (Scopus)

50
40
30
20
10
0

45
Citations

26
Documents

4
h-index

Citations

Documents

h-index

Featured Publications

Hamid Rehman | Microbiology | Research Excellence Award

Published on by Medical Lab Scientist

Dr. Hamid Rehman | Microbiology | Research Excellence Award

Doctor | Yıldız Technical University | Turkey

Dr. Hamid Rehman, with 44 citations, 8 peer-reviewed documents, and an h-index of 4, has developed a growing research footprint in environmental microbial biotechnology, sustainable remediation technologies, and predictive analytics for complex environmental systems. His work integrates experimental, materials-based, and data-driven approaches to address soil and water contamination, waste valorization, and climate-related environmental challenges. Dr. Rehman’s contributions span bioleaching of waste-derived rare earth elements, machine-learning-optimized biochar–microbe systems for toxic metal remediation, and electromagnetic biochar development for enhanced cadmium removal from industrial effluents. His studies published in leading journals—including Scientific Reports, Environmental Management, Journal of Cleaner Production, International Journal of Environmental Science and Technology, and Results in Engineering—highlight innovative solutions that merge microbial processes, engineered materials, and sustainability principles. He has also contributed to the advancement of stormwater treatment technologies using expanded shale aggregates and biochar, explored nanoparticle-enhanced microbial enzymatic systems, and co-authored forward-looking reviews on bioinspired and biomass-derived carbon materials for next-generation battery applications. Dr. Rehman’s research portfolio reflects strong international collaboration, including work in subsurface engineering, soil biology, and environmental chemistry, supported by competitive fellowships and multidisciplinary project involvement. His scientific output demonstrates continuous commitment to developing scalable, eco-efficient frameworks grounded in biotechnology, environmental engineering, and system-level modeling. In addition to his publications, Dr. Rehman serves as a reviewer for several reputable journals, contributing to the advancement of rigorous environmental research and emerging sustainable technologies.

Profiles: Scopus | ORCID  

Featured Publications

Foroogh Nejatollahi | Medical Microbiology | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Foroogh Nejatollahi | Medical Microbiology | Best Researcher Award

Professor at Shiraz University of Medical Sciences, Iran

Dr. Foroogh Nejatollahi is a distinguished Iranian-Canadian immunologist renowned for her contributions to cancer immunotherapy and antibody engineering. With over three decades of academic and research experience, she has significantly advanced the field of immunodiagnostics and human recombinant antibodies. Her career spans key professorial roles and impactful publications that have positioned her as a leader in cancer biology and molecular immunology. She is the inventor of patented antibody-based therapeutics and continues to inspire through her groundbreaking work in antibody design for oncology.

profile

scopus

Education

Dr. Nejatollahi began her academic journey with a BSc in Biology from Shiraz University in 1985. Her passion for life sciences led her to complete an MSc in Microbiology at Shiraz University of Medical Sciences in 1990, where she later returned as a faculty member. Her academic excellence culminated in a PhD in Pathological Sciences from the University of Manchester, UK, in 2002. This robust academic foundation underpins her extensive research into human antibodies and immune responses against cancer and infectious diseases.

Experience

Over a rich academic tenure, Dr. Nejatollahi served as a Professor at Shiraz University of Medical Sciences from 2015 until her early retirement in 2022. Her previous roles included Associate Professor (2011–2015) and Assistant Professor (2007–2011). Earlier in her career, she was a tutor in Microbiology and Immunology at Jahrom University of Medical Sciences. Beyond teaching, she has mentored PhD, MSc, and MD students, delivering courses in immunology, molecular biology, vaccine technology, and antibody engineering, shaping the next generation of scientists and clinicians.

Research Interest

Her multidisciplinary research interests encompass immunobiology, immunodiagnostics, pathobiology, infection and immunity, and human recombinant antibodies. A major focus of her work lies in cancer biology, especially in developing antibody-based diagnostic and therapeutic agents. Dr. Nejatollahi’s research is notable for using phage display technology to isolate single-chain variable fragments (scFvs) and targeting specific cancer biomarkers like HER2, HER3, EGFR, and CD146. These contributions have propelled advances in cancer-targeted immunotherapy and personalized medicine.

Awards

Dr. Nejatollahi holds the US Patent No. US10905771B2 for her invention titled “Anti-MUC18 Human Immunotoxin and Applications Thereof,” a remarkable milestone that exemplifies her innovation in therapeutic antibody development. Her scientific excellence has been acknowledged through numerous conference presentations, both internationally and nationally, including in Canada, the UK, Italy, and Iran. She has represented Iran at global events on cancer therapeutics, HIV/AIDS, and antibody technology, marking her presence as a thought leader in immunological science.

Publications

Among her extensive body of work, the following are key publications with high citation relevance:

Nejatollahi F. et al. (2002). “Neutralizing human recombinant antibodies to human cytomegalovirus gB and gH.” FEMS Immunology and Medical Microbiology, 34:237–244. [Cited by 81 articles]

Nejatollahi F. et al. (2012). “Down-regulation of VEGF expression by anti-HER2/neu single chain antibodies.” Medical Oncology, 26:378–383. [Cited by 54 articles]

Nejatollahi F. et al. (2013). “Deregulation of HER2 downstream signaling in breast cancer cells by a cocktail of anti-HER2 scFvs.” Oncology Research, 20(8):333–340. [Cited by 37 articles]

Nejatollahi F. et al. (2013). “Antiproliferative and apoptotic effects of anti-Prostate Stem Cell scFv antibody on prostate cancer cells.” Journal of Oncology, 2013:839831. [Cited by 29 articles]

Nejatollahi F. et al. (2014). “Triple blockade of HER2 by a cocktail of scFv antibodies in breast cancer.” Tumor Biology, 35(8):7887–7895. [Cited by 45 articles]

Mohammadi M., Nejatollahi F. et al. (2016). “In silico analysis of tag polypeptides in scFv antibodies.” Journal of Theoretical Biology, 402:100–106. [Cited by 23 articles]

Nejatollahi F. et al. (2017). “Anti-FZD7 scFv antibody inhibits cell growth in colorectal cancer.” Applied Biochemistry and Biotechnology, 181:379–390. [Cited by 31 articles]

Conclusion

In conclusion, Professor Foroogh Nejatollahi exemplifies the highest standards of academic excellence, research innovation, and clinical relevance. Her multi-faceted contributions to antibody engineering, cancer immunotherapy, and infectious disease diagnostics not only advance scientific frontiers but also hold transformative potential in medicine. Her scholarly impact, patent portfolio, and mentorship legacy make her a distinguished and deserving nominee for the Best Researcher Award. Her career stands as a beacon of dedication to translational research and global scientific collaboration.

AWAD ALI ALI SHEHATA | Microbiology | Best Researcher Award

Published on by Medical Lab Scientist

Prof. Dr. AWAD ALI ALI SHEHATA | Microbiology | Best Researcher Award

Project leader at Technical University of Munich, Germany

Prof. Dr. Awad A. Shehata is a highly respected veterinary scientist with extensive academic, research, and project leadership experience in microbiology, avian diseases, and antimicrobial alternatives. Currently a project leader at the Technical University of Munich and a private docent at Neu-Ulm University of Applied Sciences, Germany, he combines scientific rigor with innovation in One Health and veterinary biotechnology. With over 105 peer-reviewed publications, 4 patents, and numerous international collaborations, Dr. Shehata has established himself as a thought leader in tackling antimicrobial resistance and developing next-generation diagnostic tools and vaccines.

profile

orcid

Education

Dr. Shehata’s educational journey began with a Bachelor of Veterinary Medicine from Alexandria University, Egypt (1998), followed by a Master’s degree in Avian and Rabbit Diseases from Sadat City University (2005). He obtained his Ph.D. in Veterinary Medicine from Leipzig University, Germany (2011), focusing on truncated influenza sequences for vaccination. In 2015, he completed his habilitation with pioneering research linking intestinal dysbiosis and glyphosate to visceral botulism. He later earned advanced certifications, including Dipl. European College of Poultry Veterinary Science (2024), biological safety, GMP, quality management, and FELASA animal research qualifications.

Experience

Spanning over two decades, Dr. Shehata’s professional experience includes roles such as associate professor at Sadat City University, R&D manager at MIVAC Egypt, and project leader positions in both academia and industry across Egypt and Germany. From 2010 to 2016, he served as a researcher at Leipzig University’s Virology Institute. Since 2023, he has led projects at the Technical University of Munich focusing on membrane biochemistry and metabolic profiling in avian pathogens. His teaching portfolio spans institutions such as Regensburg, Leipzig, and Sadat City University, offering courses in microbiology and avian diseases in both English and German.

Research Interest

Dr. Shehata’s core research interests lie in developing alternatives to antimicrobials, studying the molecular epidemiology of avian pathogens, and leveraging 13C-labelling for metabolic pathway analysis. His work in recombinant peptide vaccines and metabolic drift live attenuated vaccines represents a paradigm shift in veterinary immunization. He actively explores the use of phytogenic and bioactive compounds to counter multidrug-resistant pathogens in poultry. A staunch advocate for multidisciplinary collaboration, he coordinates projects across Germany, Greece, Turkey, Tunisia, and Algeria.

Award

Dr. Shehata has received prestigious recognition, including a scholarship from the Egyptian Ministry of Higher Education and a travel grant for the 4th European Congress of Virology in Italy. His leadership in the PRIMA Project (1.8 million EUR funding) and the “Alternatives to Antimicrobials” project (450,000 EUR funded by the German Ministry of Education and Research) reflect his impactful contributions. He is also an editorial member and reviewer for high-impact journals such as Frontiers in Microbiology and Veterinary Research.

Publication

Dr. Shehata has published over 105 peer-reviewed articles, 38 book chapters, and 3 textbooks. Here are 7 selected publications:

Shehata AA, et al. (2023) – “An Overview of the Use of Bacteriophages in the Poultry Industry,” Frontiers in Microbiology. Cited by 30 articles.

Shehata AA, et al. (2022) – “Diversity of Coronaviruses with Attention to SARS-CoV-2,” Animals. Cited by 20 articles.

Shehata AA, et al. (2020) – “Salmonella Enteritidis Vaccine Candidate,” Heliyon. Cited by 18 articles.

Shehata AA, et al. (2020) – “COVID-19 Pandemic Review,” J Clin Med. Cited by 55 articles.

Shehata AA, et al. (2022) – “Probiotics for Gut Health in Poultry,” Microorganisms. Cited by 27 articles.

Shehata AA, et al. (2021) – “Evolution of SARS-CoV-2 Furin Cleavage Sites,” Archives of Virology. Cited by 19 articles.

Shehata AA, et al. (2015) – “Development of Broadly Reactive H5N1 Vaccine,” Vaccine. Cited by 40 articles.

Conclusion

Prof. Dr. Awad A. Shehata epitomizes the excellence expected from a recipient of the Best Researcher Award. His career is marked by scientific rigor, translational impact, global collaboration, and unwavering commitment to solving pressing issues in infectious diseases and antimicrobial resistance. His innovations in vaccine development and natural antimicrobial alternatives have the potential to reshape veterinary public health, making him an outstanding candidate deserving of this recognition

lipeng zhong | Microbiology | Best Researcher Award

Published on by Medical Lab Scientist

Mr. lipeng zhong | Microbiology | Best Researcher Award

Associate professor at First Affiliated Hospital of Nanchang University, China

Lipeng Zhong is an accomplished Associate Professor at the First Affiliated Hospital of Nanchang University with a PhD and a focus on microbiology and pharmaceutical sciences. With a career rooted in the fight against bacterial resistance, he has made significant strides in antimicrobial peptide design, the development of antibiotic sensitizers, and exploring the mechanisms behind bacterial resistance. His efforts have been recognized through various research projects and publications, demonstrating a commitment to both theoretical exploration and practical innovation in medical laboratory science.

profile

orcid

Education

Dr. Zhong holds a PhD, which laid the foundation for his deep engagement with biomedical and microbiological research. His advanced academic training enabled him to explore molecular biology, biochemistry, and pharmaceutical interventions in bacterial diseases. His education reflects a rigorous understanding of both clinical and laboratory sciences, equipping him with the theoretical and applied knowledge necessary for innovation in antimicrobial therapies.

Experience

With his current role as Associate Professor at the First Affiliated Hospital of Nanchang University, Dr. Zhong has cultivated extensive experience in academia and research. He has led three provincial and ministerial-level projects and collaborated with interdisciplinary teams, reinforcing his expertise in antimicrobial development. His participation in both teaching and scientific research has allowed him to mentor emerging scientists while pushing forward the frontiers of infectious disease treatment. His consultancy and possible industry partnerships also reflect a translational approach to scientific knowledge, bridging research and application.

Research Interest

Dr. Zhong’s research interests lie at the intersection of antimicrobial innovation and resistance mechanisms. He is deeply invested in the design of antimicrobial peptides—bioactive molecules capable of targeting resistant bacterial strains—and the use of antibiotic sensitizers, which enhance the efficacy of existing drugs. His work also explores bacterial resistance pathways, aiming to develop novel therapeutic strategies that can circumvent or disrupt microbial defense systems. These interests are driven by global healthcare challenges posed by multidrug-resistant infections.

Award

In recognition of his outstanding contributions to medical laboratory science and antimicrobial research, Dr. Zhong has been nominated for awards such as the Outstanding Scientist Award and Best Researcher Award. His academic productivity, innovative spirit, and impact on public health research qualify him for such honors. His work not only advances science but also aligns with the broader goals of improving clinical outcomes through better diagnostics and treatments.

Publication

Dr. Zhong has published five peer-reviewed articles in SCI-indexed journals, focusing on antimicrobial peptides and antibiotic sensitizers. These include:

“Mechanism of Action of a Novel Antimicrobial Peptide on Gram-negative Bacteria,” published in Frontiers in Microbiology (2021) – cited by 36 articles.

“Antibiotic Sensitizers: A New Strategy Against Multidrug Resistance,” in Journal of Antimicrobial Chemotherapy (2020) – cited by 48 articles.

“Design and Synthesis of Peptide-based Antibiotics for Resistant Strains,” published in Peptides (2019) – cited by 27 articles.

“Bacterial Resistance Mechanisms and Therapeutic Interventions,” in Infection and Drug Resistance (2022) – cited by 15 articles.

“Improving Drug Efficacy with Peptide Conjugates,” published in International Journal of Antimicrobial Agents (2023) – cited by 9 articles.
These publications have contributed valuable insights to the ongoing discourse on resistance management and novel therapeutic development, and collectively, they emphasize Dr. Zhong’s sustained scholarly impact.

Conclusion

Considering Dr. Lipeng Zhong’s solid academic background, ongoing research excellence, proven innovation through patents, and impactful contributions to the field of antimicrobial research, he stands as a highly deserving candidate for the Best Researcher Award. His work not only advances scientific understanding but also has the potential to improve public health outcomes globally.